ES2093701T3 - Procedimiento para la preparacion de suspensiones acuosas de liposomas que contienen sustancias activas. - Google Patents

Procedimiento para la preparacion de suspensiones acuosas de liposomas que contienen sustancias activas.

Info

Publication number
ES2093701T3
ES2093701T3 ES91906756T ES91906756T ES2093701T3 ES 2093701 T3 ES2093701 T3 ES 2093701T3 ES 91906756 T ES91906756 T ES 91906756T ES 91906756 T ES91906756 T ES 91906756T ES 2093701 T3 ES2093701 T3 ES 2093701T3
Authority
ES
Spain
Prior art keywords
aqueous
preparation
active substances
containing active
suspensions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91906756T
Other languages
English (en)
Inventor
Georg Dr Rossling
Andreas Sachse
Hans-Joachim Schroter
Claudia Sprenger
Cornelia Wawretschek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6405285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2093701(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2093701T3 publication Critical patent/ES2093701T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA LA PREPARACION DE SUSPENSIONES DE LIPOSOMA ACUOSO CONTENIENDO SUSTANCIAS ACTIVAS, PREPARANDOSE ESTAS SUSPENSIONES A PARTIR DE SOLUCIONES DE UNA SUSTANCIA FORMADORA DE LIPOSOMA, O UNA MEZCLA DE DICHAS SUSTANCIAS, EN UN ALCOHOL INFERIOR CON UN MAXIMO DE TRES ATOMOS DE CARBONO Y UNA FASE ACUOSA, ESTANDO EL INGREDIENTE ACTIVO DISUELTO O SUSPENDIDO EN LA SOLUCION LIPIDA Y/O LA FASE ACUOSA. EL PROCESO SE CARACTERIZA PORQUE SE INCORPORA LA FASE ACUOSA, MEDIANTE MEZCLA, EN LA SOLUCION ALCOHOLICA Y SE EXTRAE EL ALCOHOL INFERIOR MEDIANTE DESTILACION AL VACIO Y, SI ES NECESARIO, SE CONGELA-DESECA LA SUSPENSION DEL LIPOSOMA .
ES91906756T 1990-04-24 1991-04-04 Procedimiento para la preparacion de suspensiones acuosas de liposomas que contienen sustancias activas. Expired - Lifetime ES2093701T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4013580A DE4013580A1 (de) 1990-04-24 1990-04-24 Verfahren zur herstellung von wirkstoffhaltigen waessrigen liposomensuspensionen

Publications (1)

Publication Number Publication Date
ES2093701T3 true ES2093701T3 (es) 1997-01-01

Family

ID=6405285

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91906756T Expired - Lifetime ES2093701T3 (es) 1990-04-24 1991-04-04 Procedimiento para la preparacion de suspensiones acuosas de liposomas que contienen sustancias activas.

Country Status (15)

Country Link
EP (1) EP0478727B1 (es)
JP (1) JPH04506814A (es)
AT (1) ATE141503T1 (es)
AU (1) AU651969B2 (es)
CA (1) CA2041075A1 (es)
DE (2) DE4013580A1 (es)
DK (1) DK0478727T3 (es)
ES (1) ES2093701T3 (es)
FI (1) FI103178B (es)
HU (1) HU215960B (es)
IE (1) IE911350A1 (es)
NO (1) NO303481B1 (es)
PT (1) PT97468B (es)
WO (1) WO1991016039A1 (es)
ZA (1) ZA913091B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0660714B1 (en) * 1991-06-18 2003-07-02 ImaRx Pharmaceutical Corp. Novel liposomal drug delivery systems
ES2113119T3 (es) * 1993-08-06 1998-04-16 Opperbas Holding Bv Un metodo para la preparacion de vesiculas cargadas con estructuras biologicas, biopolimeros y/o oligomeros.
ATE219688T1 (de) * 1994-03-28 2002-07-15 Nycomed Imaging As Liposomen enthaltend ein röntgen- oder ultraschallkontrastmittel
WO1997035559A2 (en) * 1996-03-27 1997-10-02 Ortho Pharmaceutical Corporation Manufacture of liposomes and lipid-protein complexes by ethanolic injection and thin film evaporation
AU773515B2 (en) * 1999-02-08 2004-05-27 Alza Corporation Method for controlling liposome size
EP1519714B1 (en) * 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
WO2007012191A1 (en) 2005-07-27 2007-02-01 Protiva Biotherapeutics, Inc. Systems and methods for manufacturing liposomes
CN114344291B (zh) * 2022-02-16 2023-09-29 中南大学湘雅医院 4-苯基-1h-吡咯-3-羧酸在制备治疗骨质疏松药物中的应用、脂质体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416978A1 (de) * 1983-05-12 1984-12-06 Stauffer Chemical Co., Westport, Conn. Durch liposom vermittelte transformation eukaryotischer zellen
JPS607932A (ja) * 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソーム懸濁液およびその製法
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
FR2634375B3 (fr) * 1988-06-30 1991-07-05 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles de lipide amphiphiles sous forme de liposomes submicroniques
JP2554880B2 (ja) * 1987-05-07 1996-11-20 ポーラ化成工業株式会社 皮膚化粧料

Also Published As

Publication number Publication date
IE911350A1 (en) 1991-11-06
DK0478727T3 (es) 1997-01-20
AU7593391A (en) 1991-11-07
ATE141503T1 (de) 1996-09-15
PT97468A (pt) 1992-01-31
AU651969B2 (en) 1994-08-11
JPH04506814A (ja) 1992-11-26
FI103178B1 (fi) 1999-05-14
DE59108097D1 (de) 1996-09-26
ZA913091B (en) 1992-12-30
CA2041075A1 (en) 1991-10-25
DE4013580A1 (de) 1991-10-31
FI103178B (fi) 1999-05-14
FI916120A0 (fi) 1991-12-23
NO915012L (no) 1991-12-18
HUT62457A (en) 1993-05-28
NO303481B1 (no) 1998-07-20
NO915012D0 (no) 1991-12-18
EP0478727B1 (de) 1996-08-21
HU215960B (hu) 1999-03-29
PT97468B (pt) 1999-12-31
WO1991016039A1 (de) 1991-10-31
HU9200235D0 (en) 1992-04-28
EP0478727A1 (de) 1992-04-08

Similar Documents

Publication Publication Date Title
US4308166A (en) Process for the extemporaneous preparation of liposomes
ES8607906A1 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas conteniendo liposomas unilamilares
EP0140085A3 (en) Drug-containing lipid vesicle preparation and method for preparing them
ES8403025A1 (es) Procedimiento para preparar una solucion de insulina estabilizada.
NO172729C (no) Fremgangsmaate for fremstilling av en suspensjon av fosfolipidvesikler.
NO171443C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende syntetiske lipider
DK0497997T3 (da) Syntetiske membranvesikler indeholdende funktionelt aktive fusionspeptider som systemer til afgivelse af lægemidler
ES2093701T3 (es) Procedimiento para la preparacion de suspensiones acuosas de liposomas que contienen sustancias activas.
CA2117769A1 (en) Liposome composition
ES2078510T3 (es) Dispersion acuosa de vesiculas de fosfolipidos, procedimiento para su fabricacion y su uso.
ES2042437T1 (es) Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila.
ATE130198T1 (de) Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung.
EP0349429A3 (en) Process for the preparation of dispersible colloidal systems of amphiphilic lipids in the form of submicronic liposomes
AU7379687A (en) A process for obtaining active proteins from a biologically inactive form
KR920002165A (ko) 리포좀 생성물
AU8816098A (en) Process for preparing contrast agents
ES2094811T3 (es) Sintesis enzimatica de fosfatidos solubles a partir de fosfolipidos.
Fabczak Cholesterol-enriched liposomes affect food-vacuole formation in Tetrahymena pyriformis
ES2129342B1 (es) "formulacion de vacunas liposomales y su preparacion".
KR900701315A (ko) 인플루엔자 백신과 새로운 보조제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 478727

Country of ref document: ES